Sign in

CIK 0001819133 · Non-accelerated filer<br>Smaller reporting company

Tango Therapeutics, Inc.

Sign in to watch
Ticker
TNGX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
(857) 320-4900
Business address
201 BROOKLINE AVENUE, SUITE 901, BOSTON, MA, 02215
Former names
BCTG Acquisition Corp.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,858,086
in 6 filings, $1.9M under 10b5-1 plans

Net −$1,858,086. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Crystal Adam −$1.5M President, R&D sold 36% of stake
  2. Newcomb Jessica −$356K Principal Accounting Officer sold 23% of stake

Reading 18 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-03-01 Weber Barbara Chief Executive Officer Grant or award · Stock Option (Right to Buy) +537,273 537,273
2023-03-01 Beckman Daniella Chief Financial Officer Grant or award +32,842 96,709
2023-03-01 Beckman Daniella Chief Financial Officer Grant or award · Stock Option (Right to Buy) +197,051 197,051
2023-03-01 Barry Douglas General Counsel Grant or award +23,898 23,898
2023-03-01 Barry Douglas General Counsel Grant or award · Stock Option (Right to Buy) +143,391 143,391
2023-03-01 Huang Alan Chief Scientific Officer Grant or award +31,697 167,584
2023-03-01 Huang Alan Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +190,181 190,181
2022-12-01 Weitzman Aaron Chief Medical Officer Grant or award · Stock Option (Right to Buy) +350,000 350,000
2022-10-13 Boxer Capital, LLC 10% owner Purchase +70,000 $4.65 $325K 7,123,642
2022-10-12 Boxer Capital, LLC 10% owner Purchase +50,000 $4.43 $222K 268,524
2022-10-11 Boxer Capital, LLC 10% owner Purchase +117,000 $4.25 $498K 218,524

Page 11 of 11 · 211 trades